Marco Soro

Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease

Yang Xu, Marie Evans, Marco Soro et al. · Clinical Kidney Journal · 2021 · 69 citations · Full text

Medicine, Endocrinology, Nephrology +17

Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension

U. Haag, Julian F. Guest, John Brazier et al. · Health and Quality of Life Outcomes · 2015 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries

Andrea Marcellusi, Raffaella Viti, Paolo Sciattella et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2019 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

High prevalence of diabetes‐specific autoimmunity in first‐degree relatives of Sardinian patients with type 1 diabetes

Michela Incani, C. Serafini, Chiara Satta et al. · Diabetes/Metabolism Research and Reviews · 2016 · 17 citations

Life Sciences, Endocrinology, Immunology +17

Impact of Difelikefalin on the Health-Related Quality of Life of Haemodialysis Patients with Moderate-To-Severe Chronic Kidney Disease-Associated Pruritus: A Single-Arm Intervention Trial

James Fotheringham, Julian F. Guest, Joerg Latus et al. · Patient · 2024 · 14 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16